Legacy Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$651K Sell
7,100
-5
-0.1% -$437 0.12% 115
2026
Q1
$606K Buy
7,105
+41
+0.6% +$3.65K 0.12% 116
2025
Q4
$558K Sell
7,064
-349
-5% -$27.4K 0.1% 116
2025
Q3
$593K Buy
7,413
+500
+7% +$42.7K 0.12% 114
2025
Q2
$628K Hold
6,913
0.15% 95
2025
Q1
$648K Hold
6,913
0.16% 95
2024
Q4
$628K Sell
6,913
-9
-0.1% -$859 0.15% 94
2024
Q3
$719K Buy
6,922
+1
+0% +$102 0.17% 91
2024
Q2
$672K Sell
6,921
-4
-0.1% -$369 0.17% 91
2024
Q1
$624K Buy
6,925
+116
+2% +$9.83K 0.16% 95
2023
Q4
$543K Buy
6,809
+342
+5% +$25.7K 0.14% 100
2023
Q3
$460K Buy
6,467
+7
+0.1% +$523 0.13% 104
2023
Q2
$498K Buy
6,460
+39
+0.6% +$3.02K 0.14% 102
2023
Q1
$483K Hold
6,421
0.14% 104
2022
Q4
$506K Buy
+6,421
New +$481K 0.16% 97

Other funds holding CL

Legacy Trust's CL Position: Q2 2026 in Review

Legacy Trust reduced its Colgate-Palmolive (CL) stake by 0.07% in Q2 2026, selling an estimated $437 and leaving 7,100 shares worth $651K. The position accounts for 0.12% of the portfolio, ranked #115.

Legacy Trust first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $719K in Q3 2024. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Legacy Trust held 7,100 shares of Colgate-Palmolive worth $651K as of Q2 2026.
  • Legacy Trust sold 5 Colgate-Palmolive shares in Q2 2026, an estimated $437.
  • Colgate-Palmolive made up 0.12% of Legacy Trust's portfolio in Q2 2026, its #115 holding.
  • Legacy Trust first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • Legacy Trust's Colgate-Palmolive position peaked at $719K in Q3 2024.
  • 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.